News

SEC Filings

Document Details

Form
Filing Date
August 4, 2023
Document Date
August 4, 2023
Form Description
Pre-effective amendment to an S-3 filing
Filing Group
Registration Statements
Company
NGM Biopharmaceuticals, Inc.
Issuer
NGM BIOPHARMACEUTICALS INC

Contact Information

investor relations

ir@ngmbio.com

media relations

media@ngmbio.com